Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 11
2013 10
2014 13
2015 7
2016 11
2017 14
2018 12
2019 17
2020 28
2021 58
2022 51
2023 54
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Schulze K, Wege H, Ciccia R, Hsu WF, Vivaldi C, Wietharn B, Lin RP, Pirozzi A, Pressiani T, Dalbeni A, Natola LA, Auriemma A, Rigamonti C, Burlone M, Parisi A, Huang YH, Lee PC, Ang C, Marron TU, Pinter M, Cheon J, Phen S, Singal AG, Gampa A, Pillai A, Roehlen N, Thimme R, Vogel A, Soror N, Ulahannan S, Sharma R, Sacerdoti D, Pirisi M, Rimassa L, Lin CY, Saeed A, Masi G, Schönlein M, von Felden J, Kudo M, Cortellini A, Chon HJ, Cammà C, Pinato DJ. Celsa C, et al. Among authors: pinato dj. Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001026. Online ahead of print. Hepatology. 2024. PMID: 39028886
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
Fulgenzi CAM, Scheiner B, D'Alessio A, Mehan A, Manfredi GF, Celsa C, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Pinter M, Sharma R, Cheon J, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Napolitano A, Vivaldi C, Salani F, Masi G, Silletta M, Lo Prinzi F, Di Giacomo E, Vincenzi B, Bettinger D, Thimme R, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Pirisi M, Park JW, Kudo M, Rimassa L, Singal AG, El Tomb P, Ulahannan S, Parisi A, Chon HJ, Hsu WF, Ghittoni G, Cammà C, Stefanini B, Trevisani F, Giannini EG, Cortellini A, Pinato DJ. Fulgenzi CAM, et al. Among authors: pinato dj. JAMA Oncol. 2024 Jul 18:e242166. doi: 10.1001/jamaoncol.2024.2166. Online ahead of print. JAMA Oncol. 2024. PMID: 39023864
Consensus Statement on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy.
Kennedy AS, Brown DB, Fakih M, Jeyarajah R, Jones S, Liu D, Pinato DJ, Sangro B, Sharma NK, Sze DY, Van Cutsem E, Wasan HS. Kennedy AS, et al. Among authors: pinato dj. J Vasc Interv Radiol. 2024 Jun 15:S1051-0443(24)00398-1. doi: 10.1016/j.jvir.2024.06.006. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 38885899 Free article. Review.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Fletcher K, Cortellini A, Ganta T, Kankaria R, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Presley CJ, Owen DH, Abou Alaiwi S, Nassar AH, Lamberti G, Perrone F, Buti S, Giusti R, Filetti M, Vanella V, Mallardo D, Sussman TA, Galetta D, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Nebhan C, Berg S, Choueiri TK, Marron TU, Wang Y, Naqash AR, Johnson DB. Fletcher K, et al. Among authors: pinato dj. Cancer Lett. 2024 Aug 1;596:217001. doi: 10.1016/j.canlet.2024.217001. Epub 2024 Jun 3. Cancer Lett. 2024. PMID: 38838764 Free article.
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis.
Celsa C, Cabibbo G, Pinato DJ, Di Maria G, Enea M, Vaccaro M, Battaglia S, Rizzo GEM, Giuffrida P, Giacchetto CM, Rancatore G, Grassini MV, Cammà C. Celsa C, et al. Among authors: pinato dj. Liver Cancer. 2023 Jul 25;13(2):169-180. doi: 10.1159/000531744. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751554 Free PMC article.
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
Yang L, Murthy S, Cortellini A, Lim EA, Gonzalez M, Pinato DJ, Abdel-Malek M, Mahmoud S, Martin NM. Yang L, et al. Among authors: pinato dj. Front Endocrinol (Lausanne). 2024 Apr 12;15:1369268. doi: 10.3389/fendo.2024.1369268. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38681767 Free PMC article.
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.
Korolewicz JA, Scheiner B, Fulgenzi CAM, D'Alessio A, Cortellini A, Pascual C, Mehan A, Partridge S, Gujral DM, Mohammed W, Mohammed O, Grzesiak A, Booker L, Cleator S, Pokrovska T, Saleem W, Rackie J, Needham Y, Krell J, McNeish I, Tookman L, Park WE, Asif M, Evans JS, Pinato DJ. Korolewicz JA, et al. Among authors: pinato dj. Chemotherapy. 2024 Apr 27:1-7. doi: 10.1159/000539109. Online ahead of print. Chemotherapy. 2024. PMID: 38679017
275 results